These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 94615)

  • 1. The errors in assembly of MuLV in interferon treated cells.
    Pitha PM; Fernie B; Maldarelli F; Wivel NA
    J Supramol Struct; 1979; 12(1):35-46. PubMed ID: 94615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interferon on mouse leukaemia virus (MuLV). V. Abnormal proteins in virions of Rauscher MuLV produced in the presence of interferon.
    Pitha PM; Fernie B; Maldarelli F; Hattman T; Wivel NA
    J Gen Virol; 1980 Jan; 46(1):97-110. PubMed ID: 7351537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and serological characterization of the major envelope glycoprotein from AKR murine leukemia virus and its reactivity with autogenous immune sera from mice.
    Ihle JN; Denny TP; Bolognesi DP
    J Virol; 1976 Mar; 17(3):727-36. PubMed ID: 56459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the major glycoproteins of Friend leukemia virus (gp71) and the murine mammary tumor virus (gp52) on the surface of mouse cells.
    Holder WD; Peer GW; Bolognesi DP; Wells SA
    Cancer Res; 1976 Sep; 36(9 pt.1):3217-24. PubMed ID: 184944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoid cell surface receptor for Moloney leukemia virus envelope glycoprotein gp71. I. Binding characteristics.
    Choppin J; Schaffar-Deshayes L; Debré P; Lévy JP
    J Immunol; 1981 Jun; 126(6):2347-51. PubMed ID: 7229379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of normal mouse lymphocyte mitogen responses by xenogeneic or allogeneic antibodies to the MuLV glycoprotein gp71.
    Lee JC; Ihle JN
    J Immunol; 1976 Sep; 117(3):1033-8. PubMed ID: 182879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and cleavage processing of oncornavirus proteins during interferon inhibition of virus particle release.
    Shapiro SZ; Strand M; Billiau A
    Infect Immun; 1977 Jun; 16(3):742-7. PubMed ID: 70406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding characteristics of Rauscher leukemia virus envelope glycoprotein gp71 to murine lymphoid cells.
    Fowler AK; Twardzik DR; Reed CD; Weislow OS; Hellman A
    J Virol; 1977 Dec; 24(3):729-35. PubMed ID: 563478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon inhibits C-type virus at a posttranscriptional, prerelease step.
    Billiau A; Heremans H; Allens PT; Baron S; de Somer P
    Arch Virol; 1978; 57(3):205-20. PubMed ID: 79409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of a glycoprotein bearing a tumor transplantation antigen specific for Friend, Moloney, and Rauscher MuLV-induced tumors.
    Rogers MJ; Galetto G; Hearing VJ; Siwarski DF; Law LW
    J Immunol; 1984 Jun; 132(6):3211-7. PubMed ID: 6202777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential sensitivity of Rauscher murine leukaemia virus (MuLV-R) to interferons in two interferon-responsive cell lines.
    Allen PT; Schellekens H; Van Griensven LJ; Billiau A
    J Gen Virol; 1976 Jun; 31(3):429-35. PubMed ID: 58965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies.
    Liu DX; Gompels UA; Foa-Tomasi L; Campadelli-Fiume G
    Virology; 1993 Nov; 197(1):12-22. PubMed ID: 7692666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fucose-deficient glycoprotein precursor to Rauscher leukemia virus gp69/71.
    Naso RB; Arcement LJ; Karshin WL; Jamjoom GA; Arlinghaus RB
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2326-30. PubMed ID: 1065881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins.
    Agy MB; Acker RL; Sherbert CH; Katze MG
    Virology; 1995 Dec; 214(2):379-86. PubMed ID: 8553538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of interferon on retrovirus replication.
    Pitha PM; Bilello JA; Riggin CH
    Tex Rep Biol Med; 1981-1982; 41():603-9. PubMed ID: 6189226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis of Rauscher leukemia viral proteins.
    Naso RB; Arcement LJ; Arlinghaus RB
    Cell; 1975 Jan; 4(1):31-6. PubMed ID: 803875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid bioassay to monitor murine leukemia virus infection in mice using cellular gp 71 binding.
    Reed CD; Fowler AK
    J Virol Methods; 1982 May; 4(4-5):209-17. PubMed ID: 6286701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane receptors for murine leukemia viruses: characterization using the purified viral envelope glycoprotein, gp71.
    DeLarco J; Todaro GJ
    Cell; 1976 Jul; 8(3):365-71. PubMed ID: 8213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of high doses of poly(I).poly(C) induced mouse L cell interferon on Rauscher leukemia virus induced erythroleukemia in BALB/c mice.
    Hekman RA; Prins ME; Bosveld IJ; Trapman J
    Int J Cancer; 1981; 27(4):493-500. PubMed ID: 6168593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface receptors for ecotropic MuLV: detection and tissue distributions of free receptors in vivo.
    De Larco JE; Rapp UR; Todaro GJ
    Int J Cancer; 1978 Mar; 21(3):356-60. PubMed ID: 631935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.